Lithium succinate

Lithium succinate
Clinical data
AHFS/Drugs.com Monograph
ATC code D11AX04 (WHO)
Identifiers
PubChem (CID) 10197702
ChemSpider 8373202 YesY
ECHA InfoCard 100.036.574
Chemical and physical data
Formula C4H5LiO4
Molar mass 124.02 g/mol
3D model (Jmol) Interactive image
  (verify)

Lithium succinate, the lithium salt of succinic acid, is a drug used in the treatment of seborrhoeic dermatitis[1] and proposed for the treatment of anogenital warts.[2]

References

  1. ↑ Leeming JP (1993). "Use of topical lithium succinate in the treatment of seborrhoeic dermatitis". Dermatology (Basel). 187 (2): 149–50. doi:10.1159/000247228. PMID 8358107.
  2. ↑ Ward KA, Armstrong KD, Maw RD, Winther MD, Gilburt SJ, Dinsmore WW (1997). "A pilot study to investigate the treatment of anogenital warts with Topical Lithium Succinate cream (8% lithium succinate, 0.05% zinc sulphate)". International journal of STD & AIDS. 8 (8): 515–7. doi:10.1258/0956462971920677. PMID 9259500.


This article is issued from Wikipedia - version of the 6/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.